PMV Pharmaceuticals, Inc. (PMVP): Shareholders' Equity
$104.71M
As of 2025-12-31
$71.50M
As of 2026-06-30
-24.8%
3-year compound annual growth
-21.8%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $104.71M | -40.5% | 2026-03-06, Balance as of period end |
| 2024-12-31 | $176.08M | -22.0% | 2026-03-06, Balance as of period end |
| 2023-12-31 | $225.69M | -8.3% | 2026-03-06, Balance as of period end |
| 2022-12-31 | $246.03M | -20.3% | 2025-03-03, Balance as of period end |
| 2021-12-31 | $308.56M | -14.1% | 2024-02-29, Balance as of period end |
| 2020-12-31 | $359.12M | n/m | 2023-03-01, Balance as of period end |
| 2019-12-31 | -$70.47M | n/m | 2022-03-01, Balance as of period end |
| 2018-12-31 | -$46.14M | n/a | 2021-03-03, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $104.71M | -40.5% |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $111.38M | -28.5% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $83.05M | -37.6% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $106.63M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $47.70M | -24.5% |
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | $74.40M | -48.9% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $98.37M | +14.0% |
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | -$17.00M | n/m |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $41.77M | +217.7% |
Compare PMVP, SGMT, AVTX, AARD side by side · Screen every company in Pharmaceutical Preparations ↗